Stock Fundamentals

Company Information

▼
Company Name
CorMedix Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US21900C3088
CIK: 0001410098
CUSIP: 21900C308
Currency: USD
Full Time Employees: 64
Phone: 908 517 9500
Website: https://www.cormedix.com
Fiscal Year End: December
IPO Date: Mar 25, 2010
Description:

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Address:

300 Connell Drive, Berkeley Heights, NJ, United States, 07922

Directors & Officers

▼
Name Title Year Born
Mr. Joseph Todisco MBA CEO & Chairman of the Board of Directors 1977
Ms. Elizabeth Masson-Hurlburt B.A. Executive VP, Chief Operating Officer & Chief Integration Officer 1979
Dr. Matthew T. David M.D. EVP & Chief Business Officer 1977
Ms. Susan Blum EVP & Chief Financial Officer 1973
Ms. Kaufman Beth Zelnick Esq. EVP, Chief Legal and Compliance Officer & Corporate Secretary 1960
Ms. Beth Steinbrenner SVP & Chief Human Resource Officer NA
Donna Ucci Senior VP & Head of Global Quality NA
Dr. Tushar Mukherjee Senior VP & Head of Technical Operations NA
Mr. Michael Seckler EVP & Chief Commercial Officer 1967
Dr. Peter Sullivan BCOP, Pharm.D. Senior Vice President of Market Access NA

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 5.69M Sep 30, 2025 7.22% $0.00 6.13%
Vanguard Group Inc 4.50M Dec 31, 2025 5.71% $0.00 13.11%
Marshall Wace Asset Management Ltd 3.47M Sep 30, 2025 4.41% $0.04 34.63%
State Street Corp 1.84M Sep 30, 2025 2.33% $0.00 14.61%
Geode Capital Management, LLC 1.81M Sep 30, 2025 2.30% $0.00 13.37%
Citadel Advisors Llc 1.72M Sep 30, 2025 2.18% $0.00 0.17%
Deerfield Management Co 1.11M Dec 31, 2025 1.41% $0.16 -66.67%
UBS Group AG 1.09M Sep 30, 2025 1.38% $0.00 295.34%
Alyeska Investment Group, L.P. 850.00K Dec 31, 2025 1.08% $0.03 -32.70%
Morgan Stanley - Brokerage Accounts 843.57K Sep 30, 2025 1.07% $0.00 9.95%
Oberweis Asset Management Inc 805.12K Dec 31, 2025 1.02% $0.34 2.47%
Nuveen, LLC 695.72K Sep 30, 2025 0.88% $0.00 -52.63%
Kennedy Capital Management Inc 658.11K Dec 31, 2025 0.84% $0.16 -0.08%
Qube Research & Technologies 637.50K Sep 30, 2025 0.81% $0.01 196.21%
Northern Trust Corp 615.61K Sep 30, 2025 0.78% $0.00 8.53%
Charles Schwab Investment Management Inc 610.93K Dec 31, 2025 0.78% $0.00 4.52%
Palisades Investment Partners, LLC 576.76K Dec 31, 2025 0.73% $2.53 2.24%
Deep Track Capital, LP 500.00K Sep 30, 2025 0.63% $0.16 0.00%
Amvescap Plc. 456.91K Sep 30, 2025 0.58% $0.00 158.22%
Susquehanna International Group, LLP 448.43K Sep 30, 2025 0.57% $0.00 136.20%

Shares Statistics

▼
Shares Outstanding: 78.79M
Shares Float: 67.80M
% Insiders: 815.10%
% Institutions: 5,517.70%
Short % Float: 21.65%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 BlackRock Inc 5.69M 7.22% ▲ 6.13% Sep 30, 2025
2 Vanguard Group Inc 4.50M 5.71% ▲ 13.11% Dec 31, 2025
3 Marshall Wace Asset Management Ltd 3.47M 4.41% ▲ 34.63% Sep 30, 2025
4 State Street Corp 1.84M 2.33% ▲ 14.61% Sep 30, 2025
5 Geode Capital Management, LLC 1.81M 2.30% ▲ 13.37% Sep 30, 2025
6 Citadel Advisors Llc 1.72M 2.18% ▲ 0.17% Sep 30, 2025
7 Deerfield Management Co 1.11M 1.41% ▼ 66.67% Dec 31, 2025
8 UBS Group AG 1.09M 1.38% ▲ 295.34% Sep 30, 2025
9 Alyeska Investment Group, L.P. 850.00K 1.08% ▼ 32.70% Dec 31, 2025
10 Morgan Stanley - Brokerage Accounts 843.57K 1.07% ▲ 9.95% Sep 30, 2025

Valuation Metrics

▼
Enterprise Value: $654.58M
Trailing P/E: 3.23
Forward P/E: 6.36

Financial Highlights

▼
Market Cap: $561.77M
EBITDA: $108.20M
P/E Ratio: $3.23
PEG Ratio: $0.00
Book Value: $4.78
Earnings/Share: $2.21
Profit Margin: 75.83%
Operating Margin: 49.24%
ROA (TTM): 15.69%
ROE (TTM): 75.08%
Revenue (TTM): $214.30M
Revenue/Share (TTM): $3.17
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 810.20%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 3.39x 0.00x 0.29x -614.10x -0.01x
2023-12-31 6.97x 0.00x 0.15x -1,427.51x 0.00x
2022-12-31 9.44x 0.00x 0.11x -1,154.97x 0.00x
2021-12-31 12.44x 0.00x 0.09x -1,846.43x 0.00x
2020-12-31 11.58x 0.00x 0.10x -819.26x 0.00x
2019-12-31 5.04x 0.00x 0.20x -26.68x 0.00x
2018-12-31 2.40x -0.03x 0.74x -14,342.87x -0.23x
2017-12-31 2.12x 0.00x 0.47x -5,859.43x 0.00x
2016-12-31 5.34x 0.00x 0.19x -18,887.05x 0.00x
2015-12-31 12.11x 0.00x 0.08x -4,201.30x 0.00x
2014-12-31 3.53x 0.00x 0.29x -4,265.51x 0.00x
2013-12-31 1.74x 0.00x 2.36x -3.40x 0.00x
2012-12-31 0.70x -0.57x 1.41x -7.95x -0.09x
2011-12-31 1.94x 0.00x 0.52x -602.06x 0.00x
2010-12-31 5.59x 0.00x 0.18x -2.75x 0.00x
2009-12-31 0.10x -0.94x 7.61x -2.93x -2.28x
2008-12-31 0.10x -0.97x 8.42x -1.14x -3.11x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 30, 2025 Alan W Dunton N/A Sale 20.00K $13.00 $260.00K
Dec 18, 2025 Joseph Todisco N/A Sale 30.00K $12.00 $360.00K
Dec 09, 2025 Steven W Lefkowitz N/A Sale 40.00K $11.88 $475.20K
Oct 23, 2025 Myron Kaplan N/A Purchase 25.00K $11.02 $275.50K
Sep 12, 2025 Alan W Dunton N/A Sale 10.00K $13.13 $131.30K
Sep 12, 2025 Joseph Todisco N/A Sale 50.00K $13.00 $650.00K
Sep 11, 2025 Elizabeth Hurlburt N/A Sale 41.12K $13.08 $537.86K
Sep 09, 2025 Elizabeth Hurlburt N/A Sale 12.88K $13.51 $173.95K
Sep 09, 2025 Kaufman Beth Zelnick N/A Sale 50.00K $13.41 $670.50K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CRMD.US!